CBD of Denver Stock Forecast, Price & News

0.00 (0.00 %)
(As of 04/9/2021 12:00 AM ET)
Today's Range
Now: $0.02
50-Day Range
MA: $0.02
52-Week Range
Now: $0.02
Volume11.79 million shs
Average Volume51.32 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
CBD of Denver Inc. engages in developing and commercializing cannabidiol (CBD) products. It is involved in the research, development, and distribution of premium hemp extract products. The company was formerly known as Verde Media Group, Inc. and changed its name to CBD of Denver Inc. in 2018. CBD of Denver Inc. is based in Centennial, Colorado. CBD of Denver Inc. operates as a subsidiary of Swiss Industry Ventures AG.

Industry, Sector and Symbol

Industry Internet Retail
Current SymbolOTCMKTS:CBDD
Year FoundedN/A



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable


CBD of Denver Inc. (CBDD) Provides Corporate Update
February 5, 2021 |  finance.yahoo.com
CBD Denver Inc
January 20, 2021 |  bloomberg.com
CBD OF DENVER, INC. (CBDD) Provides Corporate Updates
December 28, 2020 |  finance.yahoo.com
See More Headlines


Overall MarketRank

0.00 out of 5 stars

Consumer Cyclical Sector

227th out of 237 stocks

Internet Retail Industry

10th out of 14 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
0.00 (0.00 %)
(As of 04/9/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CBDD News and Ratings via Email

Sign-up to receive the latest news and ratings for CBDD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

CBD of Denver (OTCMKTS:CBDD) Frequently Asked Questions

What stocks does MarketBeat like better than CBD of Denver?

Wall Street analysts have given CBD of Denver a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but CBD of Denver wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting CBD of Denver?

CBD of Denver saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 185,500 shares, an increase of 3,610.0% from the February 28th total of 5,000 shares. Based on an average trading volume of 51,902,600 shares, the days-to-cover ratio is presently 0.0 days.
View CBD of Denver's Short Interest

Who are CBD of Denver's key executives?

CBD of Denver's management team includes the following people:
  • Mr. William F. Veve, Pres, Treasurer & Director
  • Mr. Marcel R. Gamma, Chief Exec. Officer
  • Mr. Ethan Weyand, Chief Financial Officer and Member of Advisory Board
  • Dr. Syed Hussain I. Abidi Ph.D., Director and Chief Exec. Officer of Verde Media Biotechnology Division
  • Mr. Frank Alfieri, Chief Exec. Officer of the Diversified Agency Division
  • Brent LaGrange, Head of Product Devel. & Sec.

Who are some of CBD of Denver's key competitors?

What is CBD of Denver's stock symbol?

CBD of Denver trades on the OTCMKTS under the ticker symbol "CBDD."

How do I buy shares of CBD of Denver?

Shares of CBDD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CBD of Denver's stock price today?

One share of CBDD stock can currently be purchased for approximately $0.02.

What is CBD of Denver's official website?

The official website for CBD of Denver is www.cbdofdenver.com.

How can I contact CBD of Denver?

The company can be reached via phone at 720-434-3397.

This page was last updated on 4/10/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.